Kalytera Therapeutics Inc.

United States of America

Back to Profile

1-1 of 1 for Kalytera Therapeutics Inc. Sort by
Query
Aggregations
IPC Class
A61K 31/255 - Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof 1
A61P 17/00 - Drugs for dermatological disorders 1
C07C 203/10 - Esters of nitric acid having nitrate groups bound to carbon atoms of six-membered aromatic rings 1
C07C 229/18 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings 1
C07C 279/14 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups 1
See more
Found results for  patents

1.

CBD PRODRUGS, COMPOSITIONS, AND METHODS OF ADMINISTERING CBD AND CBD PRODRUGS

      
Application Number IB2017057403
Publication Number 2018/096504
Status In Force
Filing Date 2017-11-27
Publication Date 2018-05-31
Owner KALYTERA THERAPEUTICS, INC (USA)
Inventor
  • Salzman, Andrew
  • Flower, Kevin
  • Garner, C. Edwin
  • Jagtap, Parkash
  • Musa, Saana

Abstract

Compounds of Formula (I), including stereoisomers and salts thereof, and compositions, methods of treatment and prevention, and methods of preparing, the same: Formula (I) wherein X is O or a direct bond; wherein when X is O, R1 and R2 are each independently selected from -H, -SO3Na, -PO(ONa)2, -PO(OCH2CH3), -CH2PO(ONa)2, -NO2, -(L)-valine ester, -(L)-N-methyl arginine ester, -α-guanidinoglutaric acid ester, -2-iminobiotin ester, -3- hydroxy anthranilic acid ester, -(L)-nitroarginine ester, -(L)- N5-(1-iminoethyl)-(L)- ornithine (NIO) ester, -(L)-N,N dimethylarginine ester, -(L)- N6-(1-iminoethyl)-(L)-lysine (NIL) ester, -(L)- N-monomethyl-(L)-arginine (NMMA) ester, -N-amino-(L)-arginine ester, -N-propyl-(L)-arginine ester, -S-methyl-(L)-thiocitrulline ester, -methyl-(L)-NIO ester, - vinyl -(L)-NIO ester, and -propenyl-(L)-NK) ester; and wherein when X is a direct bond, R1 and R2 are Formula (II).

IPC Classes  ?

  • C07F 9/38 - Phosphonic acids [R—P(:O)(OH)2]Thiophosphonic acids
  • C07C 279/14 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
  • C07C 203/10 - Esters of nitric acid having nitrate groups bound to carbon atoms of six-membered aromatic rings
  • C07C 305/24 - Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
  • C07C 229/18 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
  • C07F 9/40 - Esters thereof
  • A61K 31/255 - Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
  • A61P 17/00 - Drugs for dermatological disorders